BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20923402)

  • 1. PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.
    Kwon MJ; Wang R; Ma J; Sun Z
    Endocr Metab Immune Disord Drug Targets; 2010 Dec; 10(4):367-72. PubMed ID: 20923402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C-theta inhibitors: a novel therapy for inflammatory disorders.
    Chand S; Mehta N; Bahia MS; Dixit A; Silakari O
    Curr Pharm Des; 2012; 18(30):4725-46. PubMed ID: 22830352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection.
    Manicassamy S; Yin D; Zhang Z; Molinero LL; Alegre ML; Sun Z
    J Immunol; 2008 Jul; 181(1):513-20. PubMed ID: 18566417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C(theta) in T cell activation.
    Isakov N; Altman A
    Annu Rev Immunol; 2002; 20():761-94. PubMed ID: 11861617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intervention of PKC-θ as an immunosuppressive regimen.
    Sun Z
    Front Immunol; 2012; 3():225. PubMed ID: 22876242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKC theta cooperates with PKC alpha in alloimmune responses of T cells in vivo.
    Gruber T; Hermann-Kleiter N; Pfeifhofer-Obermair C; Lutz-Nicoladoni C; Thuille N; Letschka T; Barsig J; Baudler M; Li J; Metzler B; Nüsslein-Hildesheim B; Wagner J; Leitges M; Baier G
    Mol Immunol; 2009 Jun; 46(10):2071-9. PubMed ID: 19356803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.
    Zhang EY; Kong KF; Altman A
    Adv Pharmacol; 2013; 66():267-312. PubMed ID: 23433459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production.
    Fan YY; Ly LH; Barhoumi R; McMurray DN; Chapkin RS
    J Immunol; 2004 Nov; 173(10):6151-60. PubMed ID: 15528352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis.
    Marsland BJ; Nembrini C; Grün K; Reissmann R; Kurrer M; Leipner C; Kopf M
    J Immunol; 2007 Mar; 178(6):3466-73. PubMed ID: 17339441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective function of PKC-theta in T cells.
    Manicassamy S; Gupta S; Sun Z
    Cell Mol Immunol; 2006 Aug; 3(4):263-70. PubMed ID: 16978534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cell-derived factors inhibit T effector activation and induce T regulatory cells by suppressing PKC-θ activation.
    Mohib K; AlKhamees B; Zein HS; Allan D; Wang L
    PLoS One; 2012; 7(3):e32420. PubMed ID: 22412871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR-induced sumoylation of the kinase PKC-θ controls T cell synapse organization and T cell activation.
    Wang XD; Gong Y; Chen ZL; Gong BN; Xie JJ; Zhong CQ; Wang QL; Diao LH; Xu A; Han J; Altman A; Li Y
    Nat Immunol; 2015 Nov; 16(11):1195-203. PubMed ID: 26390157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C theta (PKCtheta): a key player in T cell life and death.
    Hayashi K; Altman A
    Pharmacol Res; 2007 Jun; 55(6):537-44. PubMed ID: 17544292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells.
    Manicassamy S; Sadim M; Ye RD; Sun Z
    J Mol Biol; 2006 Jan; 355(3):347-59. PubMed ID: 16309697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-theta (PKC theta): a key enzyme in T cell life and death.
    Altman A; Villalba M
    J Biochem; 2002 Dec; 132(6):841-6. PubMed ID: 12473184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL.
    Manicassamy S; Gupta S; Huang Z; Sun Z
    J Immunol; 2006 Jun; 176(11):6709-16. PubMed ID: 16709830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKCtheta: A potential therapeutic target for T-cell-mediated diseases.
    Chaudhary D; Kasaian M
    Curr Opin Investig Drugs; 2006 May; 7(5):432-7. PubMed ID: 16729719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of retinoid X receptor responsive element-dependent transcription in T lymphocytes by Ser/Thr phosphatases: functional divergence of protein kinase C (PKC)theta; and PKC alpha in mediating calcineurin-induced transactivation.
    Ishaq M; Fan M; Wigmore K; Gaddam A; Natarajan V
    J Immunol; 2002 Jul; 169(2):732-8. PubMed ID: 12097375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells.
    Hehner SP; Li-Weber M; Giaisi M; Dröge W; Krammer PH; Schmitz ML
    J Immunol; 2000 Apr; 164(7):3829-36. PubMed ID: 10725744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.